SCHEMBL26651006

SCHEMBL26651006

COc1c(C=O)cn(S(=O)(=O)c2ccc(C)nc2)c1-c1ccc(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.36
▸ PTGS1 P23219 2/20 0.36
▸ HTR2A P28223 3/20 0.36
▸ KCNH2 Q12809 3/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ SCN9A Q15858 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ KIT P10721 1/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ UBE2N P61088 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ GPBAR1 Q8TDU6 1/20 0.31
▸ ALDH3A1 P30838 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30287361 1.00 PTGS2 (0.36) PTGS2PTGS1HTR2AKCNH2HTR2C
SCHEMBL30287363 0.90 ERN1 (0.41) PTGS2PTGS1HTR2AKCNH2HTR2C
SCHEMBL28996379 0.90 ERN1 (0.41) PTGS2PTGS1HTR2AKCNH2HTR2C
SCHEMBL25189031 0.86 POLB (0.40) PTGS2PTGS1KCNH2POLBKMT2A
SCHEMBL31019968 0.86 POLB (0.40) PTGS2PTGS1KCNH2POLBKMT2A
SCHEMBL28996389 0.84 PTGS2 (0.40) PTGS2PTGS1SCN9APOLBKIT
SCHEMBL30287358 0.84 PTGS2 (0.40) PTGS2PTGS1SCN9APOLBKIT
SCHEMBL30287367 0.83 PTGS2 (0.38) PTGS2PTGS1SCN9APOLBKIT
SCHEMBL28996387 0.83 PTGS2 (0.38) PTGS2PTGS1SCN9APOLBKIT
SCHEMBL30963578 0.83 MEN1 (0.40) PTGS2PTGS1HTR2AHTR2CPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115884968-B Novel acid secretion inhibitor and use thereof 日东制药株式会社 2024-06-21 — — CN disclosed
US-20230373954-A1 NOVEL ACID SECRETION INHIBITOR AND USE THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-23 — — US disclosed
CN-115884968-A Novel acid secretion inhibitor and use thereof 日东制药株式会社 2023-03-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373954-A1 NOVEL ACID SECRETION INHIBITOR AND USE THEREOF SLC10A2, SLC10A1, ASIC1 PTGS2 275/4885PTGS1 772/4885HTR2A 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback